Cargando…
Hyperthyroidism is associated with breast cancer risk and mammographic and genetic risk predictors
BACKGROUND: Despite the biological link between thyroid hormones and breast cancer cell proliferation shown in experimental studies, little is known about the association between hyperthyroidism and breast cancer, as well as its association with the most common mammographic and genetic risk predicto...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446157/ https://www.ncbi.nlm.nih.gov/pubmed/32838791 http://dx.doi.org/10.1186/s12916-020-01690-y |
_version_ | 1783574112926433280 |
---|---|
author | Yang, Haomin Holowko, Natalie Grassmann, Felix Eriksson, Mikael Hall, Per Czene, Kamila |
author_facet | Yang, Haomin Holowko, Natalie Grassmann, Felix Eriksson, Mikael Hall, Per Czene, Kamila |
author_sort | Yang, Haomin |
collection | PubMed |
description | BACKGROUND: Despite the biological link between thyroid hormones and breast cancer cell proliferation shown in experimental studies, little is known about the association between hyperthyroidism and breast cancer, as well as its association with the most common mammographic and genetic risk predictors for breast cancer. METHODS: This study estimates the incidence rate ratios (IRRs) of breast cancer among women diagnosed with hyperthyroidism, compared to those who are not, using two cohorts: a Swedish national cohort of the general female population (n = 3,793,492, 2002–2011) and the Karolinska Mammography Project for Risk Prediction of Breast Cancer (KARMA, n = 69,598, 2002–2017). We used logistic regression to estimate the odds ratios (ORs) of hyperthyroidism according to the mammographic and genetic risk predictors for breast cancer. RESULTS: An increased risk of breast cancer was observed in patients in the national cohort with hyperthyroidism (IRR = 1.23, 95% CI = 1.12–1.36), particularly for toxic nodular goiter (IRR = 1.38, 95% CI = 1.16–1.63). Hyperthyroidism was associated with higher body mass index, early age at first birth, and lower breastfeeding duration. Higher mammographic density was observed in women with toxic nodular goiter, compared to women without hyperthyroidism. Additionally, among genotyped women without breast cancer in the KARMA cohort (N = 11,991), hyperthyroidism was associated with a high polygenic risk score (PRS) for breast cancer overall (OR = 1.98, 95% CI = 1.09–3.60) and for estrogen receptor-positive specific PRS (OR = 1.90, 95% CI = 1.04–3.43). CONCLUSION: Hyperthyroidism is associated with an increased risk of breast cancer, particularly for patients with toxic nodular goiter. The association could be explained by higher mammographic density among these women, as well as pleiotropic genetic variants determining shared hormonal/endocrine factors leading to the pathology of both diseases. |
format | Online Article Text |
id | pubmed-7446157 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-74461572020-08-26 Hyperthyroidism is associated with breast cancer risk and mammographic and genetic risk predictors Yang, Haomin Holowko, Natalie Grassmann, Felix Eriksson, Mikael Hall, Per Czene, Kamila BMC Med Research Article BACKGROUND: Despite the biological link between thyroid hormones and breast cancer cell proliferation shown in experimental studies, little is known about the association between hyperthyroidism and breast cancer, as well as its association with the most common mammographic and genetic risk predictors for breast cancer. METHODS: This study estimates the incidence rate ratios (IRRs) of breast cancer among women diagnosed with hyperthyroidism, compared to those who are not, using two cohorts: a Swedish national cohort of the general female population (n = 3,793,492, 2002–2011) and the Karolinska Mammography Project for Risk Prediction of Breast Cancer (KARMA, n = 69,598, 2002–2017). We used logistic regression to estimate the odds ratios (ORs) of hyperthyroidism according to the mammographic and genetic risk predictors for breast cancer. RESULTS: An increased risk of breast cancer was observed in patients in the national cohort with hyperthyroidism (IRR = 1.23, 95% CI = 1.12–1.36), particularly for toxic nodular goiter (IRR = 1.38, 95% CI = 1.16–1.63). Hyperthyroidism was associated with higher body mass index, early age at first birth, and lower breastfeeding duration. Higher mammographic density was observed in women with toxic nodular goiter, compared to women without hyperthyroidism. Additionally, among genotyped women without breast cancer in the KARMA cohort (N = 11,991), hyperthyroidism was associated with a high polygenic risk score (PRS) for breast cancer overall (OR = 1.98, 95% CI = 1.09–3.60) and for estrogen receptor-positive specific PRS (OR = 1.90, 95% CI = 1.04–3.43). CONCLUSION: Hyperthyroidism is associated with an increased risk of breast cancer, particularly for patients with toxic nodular goiter. The association could be explained by higher mammographic density among these women, as well as pleiotropic genetic variants determining shared hormonal/endocrine factors leading to the pathology of both diseases. BioMed Central 2020-08-25 /pmc/articles/PMC7446157/ /pubmed/32838791 http://dx.doi.org/10.1186/s12916-020-01690-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Yang, Haomin Holowko, Natalie Grassmann, Felix Eriksson, Mikael Hall, Per Czene, Kamila Hyperthyroidism is associated with breast cancer risk and mammographic and genetic risk predictors |
title | Hyperthyroidism is associated with breast cancer risk and mammographic and genetic risk predictors |
title_full | Hyperthyroidism is associated with breast cancer risk and mammographic and genetic risk predictors |
title_fullStr | Hyperthyroidism is associated with breast cancer risk and mammographic and genetic risk predictors |
title_full_unstemmed | Hyperthyroidism is associated with breast cancer risk and mammographic and genetic risk predictors |
title_short | Hyperthyroidism is associated with breast cancer risk and mammographic and genetic risk predictors |
title_sort | hyperthyroidism is associated with breast cancer risk and mammographic and genetic risk predictors |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446157/ https://www.ncbi.nlm.nih.gov/pubmed/32838791 http://dx.doi.org/10.1186/s12916-020-01690-y |
work_keys_str_mv | AT yanghaomin hyperthyroidismisassociatedwithbreastcancerriskandmammographicandgeneticriskpredictors AT holowkonatalie hyperthyroidismisassociatedwithbreastcancerriskandmammographicandgeneticriskpredictors AT grassmannfelix hyperthyroidismisassociatedwithbreastcancerriskandmammographicandgeneticriskpredictors AT erikssonmikael hyperthyroidismisassociatedwithbreastcancerriskandmammographicandgeneticriskpredictors AT hallper hyperthyroidismisassociatedwithbreastcancerriskandmammographicandgeneticriskpredictors AT czenekamila hyperthyroidismisassociatedwithbreastcancerriskandmammographicandgeneticriskpredictors |